BridgeMD
Tests treatment safety and results for Obsessive Compulsive Disorder (OCD)
Official title Efficacy and Mechanism of Augmentation of Cognitive Behavioral Therapy With Transcranial Alternating Current Stimulation(tACS) for Obsessive-Compulsive Disorder (OCD)
ClinicalTrials.gov ID: NCT06717165
What this study is testing
What is ERP combined with high-definition active tACS?
ERP combined with high-definition active tACS is an investigational medicine, being studied as a potential treatment for obsessive compulsive disorder (ocd).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to evaluate the feasibility and clinical outcome of the Exposure-based Cognitive-Behavioral Therapy (CBT) concurrent with Transcranial Alternating Current Stimulation (tACS) using individualized stimulation frequency in treating obsessive-compulsive disorder (OCD) patients, and explores the potential neural mechanisms of treatment effect by magnetic resonance imaging (MRI) and electroencephalography (EEG).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- The investigators recruited outpatient adults with OCD confirmed by the Mini-International Neuropsychiatric Interview (MINI). The following inclusion...
You likely can't join if
- were also applied: Inclusion Criteria:
- 18-60 years old
- With at least 9 years of education
- Y-BOCS score ≥16
- No history of serious medical, neurological illness or other psychotic disorders other than OCD (anxiety or mild to moderate depression secondary to...
- Medication-free or had received stable medication for at least 8 weeks before entering the study and continued the same medication throughout the...
See the full eligibility criteria
- The investigators recruited outpatient adults with OCD confirmed by the Mini-International Neuropsychiatric Interview (MINI). The following inclusion and
- were also applied: Inclusion Criteria:
- 18-60 years old
- With at least 9 years of education
- Y-BOCS score ≥16
- No history of serious medical, neurological illness or other psychotic disorders other than OCD (anxiety or mild to moderate depression secondary to OCD was not exclusionary)
- Medication-free or had received stable medication for at least 8 weeks before entering the study and continued the same medication throughout the study Exclusion Criteria:
- History of serious medical, neurological illness or other psychotic disorders other than OCD
- OCD symptoms are severe, preventing the patient from completing the required assessment and examination
- Serious suicide risk
- Women who are pregnant or planning to become pregnant
- Currently taking antiepileptic medication
- Clinically significant physical illnesses or laboratory test abnormalities that have clinical significance
- Previous completion of a full course of CBT/ERP treatment
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.